NM_000807.4:c.*4427G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000807.4(GABRA2):c.*4427G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.63 in 150,812 control chromosomes in the GnomAD database, including 30,623 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.63 ( 30623 hom., cov: 31)
Consequence
GABRA2
NM_000807.4 3_prime_UTR
NM_000807.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.159
Publications
1 publications found
Genes affected
GABRA2 (HGNC:4076): (gamma-aminobutyric acid type A receptor subunit alpha2) GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013]
GABRA2 Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 78Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.758 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRA2 | NM_000807.4 | c.*4427G>A | 3_prime_UTR_variant | Exon 10 of 10 | ENST00000381620.9 | NP_000798.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.630 AC: 94965AN: 150694Hom.: 30580 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
94965
AN:
150694
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.630 AC: 95052AN: 150812Hom.: 30623 Cov.: 31 AF XY: 0.631 AC XY: 46476AN XY: 73658 show subpopulations
GnomAD4 genome
AF:
AC:
95052
AN:
150812
Hom.:
Cov.:
31
AF XY:
AC XY:
46476
AN XY:
73658
show subpopulations
African (AFR)
AF:
AC:
30998
AN:
41358
American (AMR)
AF:
AC:
8393
AN:
15084
Ashkenazi Jewish (ASJ)
AF:
AC:
2394
AN:
3446
East Asian (EAS)
AF:
AC:
2795
AN:
5086
South Asian (SAS)
AF:
AC:
3747
AN:
4810
European-Finnish (FIN)
AF:
AC:
6308
AN:
10510
Middle Eastern (MID)
AF:
AC:
188
AN:
288
European-Non Finnish (NFE)
AF:
AC:
38342
AN:
67228
Other (OTH)
AF:
AC:
1325
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1760
3520
5279
7039
8799
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
782
1564
2346
3128
3910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2278
AN:
3468
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.